Suzanne Rivera named new VP for research

Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as Case Western Reserve´s new vice president for research, effective this month. Rivera, the university´s associate vice president for research since January 2011, emerged as the top choice after an extensive process involving campuswide nominations of internal university candidates. Since coming to CWRU, Rivera has distinguished herself through a commitment to collaboration and a focus on systems and processes.
Read more about her.


Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
December 9, 2014  

Marquette University

Marquette University, with a generous grant from the Templeton Religion Trust, is pleased to announce a new research initiative on the topics of the self, motivation, and virtue. Approximately ten research proposals at $190,000 each will be funded through this initiative.

The grant competition has four primary aims:
1. To support innovative research on the self, motivation, and virtue.
2. To encourage methodological innovation in the study of the self, motivation, and virtue.
3. To encourage interdisciplinary team work, specifically between social science and humanities.
4. To support scholars new to the investigation of these topics or who have not received funding elsewhere. Research collaborations between younger and more established scholars are especially encouraged.

Research into character and virtue is often conducted by scholars from within a single disciplinary perspective. This disciplinary isolationism is not maximally productive of new knowledge about virtue. To ensure that research funded by this proposal closes the disciplinary gap, successful teams will be comprised of at least one humanist and one scientist who are fully and equally invested in the research project, from its inception to its completion. The aim here is to encourage awardees to think outside of their own disciplinary perspectives, and to broaden their research horizons in ways conducive to creative collaborations and results.

For more information on this extended deadline, please visit the Marquette University website or contact Marquette at: smvproject@marquette.edu.

 
Foundation of the National Student Nurses’ Association (FNSNA)

The Foundation of the National Student Nurses' Association is accepting applications for its Marilyn Bagwell Leadership Development Grant, an annual program to foster the development of leadership skills in nursing students at the school level.

A grant of up to $2,500 will be awarded to one nursing program that wishes to establish or enhance its involvement in NSNA. The funds may be used to create an official NSNA chapter; to support special initiatives/activities of an official chapter where leadership principles can be applied and learned; and to promote the advancement of the resolutions adopted by NSNA within the last ten years.

The school that receives the grant will be recognized at the 63rd NSNA Annual Convention in Phoenix, Arizona, in April 2015.

A faculty advisor from the nursing program must apply for the grant. Individual students are not eligible.

For complete program guidelines and application instructions, visit the foundation FNSNA website.

 
The Ohio Clinical Trial Collaborative (OCTC)

The Ohio Clinical Trial Collaborative OCTC is developing partnerships with the drug industry to include Biotech and Pharmaceutical industries to perform clinical drug trials phase I-4. The OCTC is a network of Ohio based hospitals led by working groups in areas such as neuro oncology, pediatrics, infectious disease, and neuroscience. The OCTC was launched at the BIO2014 which was attended by 15,000 biotech and pharmaceutical executives in San Diego resulting in numerous leads for potential drug trials.

The OCTC has plans to attend additional biotech and pharmaceuticals shows. The OCTC is looking for additional working groups interested in developing a sell sheet that can then be searched on the World Wide Web and will begin sales and marketing activities to identify opportunities with industry. If there are companies that individuals would like OCTC to target, the group welcomes that feedback.

Review the OCTC working website at: http://ohioclintrials.org.

Contact Joe Peter at 216-702-5314 for more information.

 
The Cleveland Area Reliant IRB Review Process

The Cleveland Area Reliant Institutional Review Board (IRB) Review process includes participation by the Case Western Reserve University (CWRU) Social, Behavioral, and Educational Research (SBER) IRB, the Cleveland Clinic (CC) IRB, MetroHealth Medical Center (MHMC) IRB, and University Hospitals Case Medical Center (UHCMC) IRB. The process relies on executed IRB Authorization Agreements (IAA) between the institutions. These agreements document that all applicable human research subjects protection considerations will be made by one Institutional Review Board (IRB), which will be deemed the IRB of record. The IRBs of the other Cleveland area institutions will accept the approval of the IRB of record through the Reliant Review process. The goal is to eliminate duplication of effort and multiple applications for submission of the same protocol, and to encourage scientific collaboration among the affiliated institutions.

What types of studies are eligible for the Reliant Review Process?
Any type of human research study could be eligible for the Reliant Review process. These include but are not limited to investigator-initiated, federally-funded, foundation-supported, industry-sponsored, and non-funded studies.

The fundamental requirement is that a collaborating investigator must be named at each site where the research will occur. It is important for the Principal Investigator at the lead study site to work with the IRB of record throughout the Reliant Review Process to initiate acceptance of IRB approval at each collaborating site.

For further information, contact Kim Volarcik at (216) 368-0134 or kav6@case.edu.

 
Division of Infectious Diseases & HIV Medicine, CWRU and UH Case Medical Center

Announcement of Infectious Diseases Research Support from STERIS Corporation
The Division of Infectious Diseases & HIV Medicine at Case Western Reserve University and University Hospitals Case Medical Center, with funds from STERIS Corporation, will provide seed money to faculty to foster research in emerging and healthcare-associated infections.

Announcement of Infectious Diseases Research Support from the Infectious Diseases & Immunology Institute (IDII)
The Infectious Diseases & Immunology Institute (IDII) at Case Western Reserve University will provide seed money to young investigators (within 5 years of appointment) to foster interdisciplinary research in infectious diseases and immunology.

For more information on these opportunities, please contact Martha Salata at 844-1988 or mks18@case.edu or visit the Center’s website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.